WebJan 31, 2024 · The primary end point was the incidence of treatment-emergent adverse events (TEAEs). Results: A total of 93 patients were randomized and received treatment. TEAEs occurred in 55.9% of patients. The incidence of TEAEs was comparable among all the groups. Serious TEAEs occurred in one patient (1.1%), with no deaths observed. WebJun 28, 2024 · More information can be found on www.chinadrugtrials.org.cn. About Leber's Hereditary Optic Neuropathy. Leber hereditary optic neuropathy (LHON) ...
China Trials Global Clinical Development Conference & Exhibition ...
WebAug 10, 2024 · EXPLORER-CN is a Phase 3 multicenter, double-blind, randomized, placebo-controlled registrational study designed to evaluate the safety and efficacy of mavacamten in Chinese patients with ... WebJan 10, 2024 · EXPLORER-CN is a Phase 3 multicenter, double-blind, randomized, placebo-controlled registrational study designed to evaluate the safety and efficacy of mavacamten in Chinese patients with... share certificate generator online
LianBio Announces First Patient Dosed in Registrational Phase 3 ...
WebGitHub - reycn/china-drug-trials-crawler: A web crawler for Chinadrugtrials.org.cn, written in Python 3.6+. reycn china-drug-trials-crawler master 1 branch 0 tags 9 commits Failed … Web访问验证. 别离开,为了更好的访问体验,请滑动滑块进行验证,通过后即可继续访问网页 WebOct 24, 2024 · 作为一名入行四年多的cra,深知想成为一名优秀的临研人,必须不断的学习,不断提升自己的专业技能,接下来和大家分享一下临研人常用的学习网站,干货如下: pool liner bottom pad